Foetal-Placental Neuroendocrine Development

Foetal Placental Neuroendocrine development involves mother, foetus, and placenta, and stress is a key element activating a series of physiological adaptive responses. Oxytocin (OT) is the neurohormone whose major target is uterine contractility and placenta represents a novel source that contributes to the mechanisms of parturition. Among the others, neurohormones, relaxin, parathyroid hormone-related protein, opioids, neurosteroids, and monoamines are expressed and secreted from placental tissues at parturition.

 

    Related Conference of Foetal-Placental Neuroendocrine Development

    October 04-05, 2020

    World Summit on Blood Glucose Monitoring

    Beijing, China
    October 07-08, 2020

    International Summit on Diabetes

    Barcelona, Spain
    October 14-15, 2020

    World Congress on Endocrinology & Diabetes

    Rome, Italy
    October 14-15, 2020

    Global Congress on Endocrinology and Gynecology

    Sydney, Australia
    October 30-31, 2020

    Annual Summit on Metabolomics

    Vancouver, Canada
    November 09-10, 2020

    International Congress and Expo on Diabetic Care

    Bangkok, Thailand
    November 13-14, 2020

    International Conference on Diabetes and Heart Diseases

    Bangkok, Thailand
    November 16-17, 2020

    World Congress and Expo on Diabetes

    Kyoto, Japan
    November 16-17, 2020

    2nd Asia Pacific Diabetes and Endocrinology Congress

    Brisbane, Australia
    November 18-19, 2020

    Annual congress on Diabetes and Endocrinology Congress

    Bangkok, Thailand
    December 07-08, 2020

    13th World Congress on Endocrinology and Metabolic Disorders

    Auckland, Newzealand
    March 17-18, 2021

    30th European Diabetes Congress

    Barcelona, Spain
    October 18-19, 2021

    2nd Annual Summit on Diabetes and Endocrinology

    Paris, France

    Foetal-Placental Neuroendocrine Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in